(Q50880520)
Statements
2023
"for breakthrough research advancing chimeric antigen receptor T-cell therapy for the treatment of cancer." (English)
1 reference
23 September 2023
Identifiers
Sitelinks
Wikipedia(4 entries)
- dewiki Michel Sadelain
- enwiki Michel Sadelain
- frwiki Michel Sadelain
- ruwiki Саделайн, Мишель